GLP-1 (S)

GLP-1 (S) is a GLP-1 receptor agonist studied for its effects on appetite regulation and blood sugar control.

The compound activates GLP-1 receptors in the brain and pancreas, slowing gastric emptying and boosting glucose dependent insulin release after meals.

In large phase 3 clinical trials, agonists in this class produced average body weight reductions of roughly 15% over 68 weeks, a result that continues to drive research into incretin based approaches to obesity and metabolic disease.